Healthcare Services - Hospital Operations & Health Insurance (Latin America)
Strategic Profile
Auna has a solid market position in Latin America with significant upside potential, supported by strategic initiatives and favorable analyst ratings despite revenue growth challenges. The company is expanding its oncology services with new specialized centers and increasing participation with major Mexican insurance networks to drive patient access in 2026.
Cyborg Score Rationale
Analyst sentiment is predominantly positive with five buy ratings and two holds, and a consensus target price of $7.20 offering 35% upside potential. Strong cash flow and ROE support operational stability, though modest revenue growth presents headwinds.
Top Insights
Strong analyst sentiment with 5 buy ratings, 2 holds, and 35% upside consensus target
Robust free cash flow of $137M provides flexibility for growth investments and debt service
Expansion of specialized oncology services and Mexican insurance partnerships expected to drive 2026 growth
Forward P/E of 5.33 suggests potential undervaluation relative to earnings power
Named Competitors
Hospital Networks — Traditional hospital and clinic operators in Latin America
Integrated Healthcare Providers — Healthcare systems combining hospital operations with insurance products
Recent Developments
(February 2026) Auna stock trading near technical oversold levels (RSI 37.24) with positive MACD momentum signaling potential buying opportunity
(2025) Inauguration of new oncology center at Doctors Hospital as center of excellence
(2026 Outlook) Planned expansion of participation with major Mexican insurance companies' preferred provider networks
Open the full interactive Auna S.A. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.